Sanofi CEO Finally Scores With $11.6B Buyout of Biogen's Spinoff Bioverativ Post author:Sam Post published:January 21, 2018 Post category:BioPharma The deal has Sanofi paying $105 per share in cash. Source: BioSpace You Might Also Like 1-Year old Biotech Startup LifeOmic to Create 225 Jobs at New HQ December 4, 2017 Abbott Introduces Heartmate 3 Left Ventricular Assist System – The Latest Milestone In Therapy For Advanced Heart Failure Patients August 27, 2017 <b>Reflexion Health</b> To Offer New England???s First In-Home Virtual Exercise Rehabilitation Program At <b>Yale New Haven Hospital</b> February 8, 2017
Abbott Introduces Heartmate 3 Left Ventricular Assist System – The Latest Milestone In Therapy For Advanced Heart Failure Patients August 27, 2017
<b>Reflexion Health</b> To Offer New England???s First In-Home Virtual Exercise Rehabilitation Program At <b>Yale New Haven Hospital</b> February 8, 2017
